These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37379655)

  • 21. Potential Role for Mycobacterium tuberculosis Specific IL-2 and IFN-γ Responses in Discriminating between Latent Infection and Active Disease after Long-Term Stimulation.
    Sun Q; Wei W; Sha W
    PLoS One; 2016; 11(12):e0166501. PubMed ID: 28033330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic Accuracy of Early Secretory Antigenic Target-6-Free Interferon-gamma Release Assay Compared to QuantiFERON-TB Gold In-tube.
    Nemes E; Abrahams D; Scriba TJ; Ratangee F; Keyser A; Makhethe L; Erasmus M; Mabwe S; Bilek N; Rozot V; Geldenhuys H; Hatherill M; Lempicki MD; Holm LL; Bogardus L; Ginsberg AM; Blauenfeldt T; Smith B; Ellis RD; Loxton AG; Walzl G; Andersen P; Ruhwald M
    Clin Infect Dis; 2019 Oct; 69(10):1724-1730. PubMed ID: 30668657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Strong purified protein derivative responses are associated with poor mycobacterium inhibition in latent TB.
    Kang JS; Cherian A; Gan SH; Lee TH; Lee KC; Chee CB; Doherty TM; Wang YT; Seah GT
    Eur Respir J; 2010 Aug; 36(2):348-54. PubMed ID: 19996195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New tools for detecting latent tuberculosis infection: evaluation of RD1-specific long-term response.
    Butera O; Chiacchio T; Carrara S; Casetti R; Vanini V; Meraviglia S; Guggino G; Dieli F; Vecchi M; Lauria FN; Marruchella A; Laurenti P; Singh M; Caccamo N; Girardi E; Goletti D
    BMC Infect Dis; 2009 Nov; 9():182. PubMed ID: 19930588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Broad adaptive immune responses to M. tuberculosis antigens precede TST conversion in tuberculosis exposed household contacts in a TB-endemic setting.
    Buchwald UK; Adetifa IM; Bottomley C; Owiafe PK; Donkor S; Bojang AL; Sutherland JS
    PLoS One; 2014; 9(12):e116268. PubMed ID: 25549338
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Mpande CAM; Steigler P; Lloyd T; Rozot V; Mosito B; Schreuder C; Reid TD; Bilek N; Ruhwald M; Andrews JR; Hatherill M; Little F; Scriba TJ; Nemes E
    Front Immunol; 2021; 12():712480. PubMed ID: 34526988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of a new ESAT-6/CFP-10 peptide-based gamma interferon assay and a tuberculin skin test for tuberculosis screening in a moderate-risk population.
    Porsa E; Cheng L; Seale MM; Delclos GL; Ma X; Reich R; Musser JM; Graviss EA
    Clin Vaccine Immunol; 2006 Jan; 13(1):53-8. PubMed ID: 16426000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Profile of interferon-gamma response to latency-associated and novel in vivo expressed antigens in a cohort of subjects recently exposed to Mycobacterium tuberculosis.
    Araujo LS; da Silva NBM; da Silva RJ; Leung JAM; Mello FCQ; Saad MHF
    Tuberculosis (Edinb); 2015 Dec; 95(6):751-757. PubMed ID: 26421415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of resuscitation promoting factors to screen for tuberculosis infection in household-exposed children in The Gambia.
    van Loon W; Gomez MP; Jobe D; Franken KLMC; Ottenhoff THM; Coninx M; Kestens L; Sutherland JS; Kampmann B; Tientcheu LD
    BMC Infect Dis; 2020 Jul; 20(1):469. PubMed ID: 32615981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term Stability of Resistance to Latent Mycobacterium tuberculosis Infection in Highly Exposed Tuberculosis Household Contacts in Kampala, Uganda.
    Stein CM; Nsereko M; Malone LL; Okware B; Kisingo H; Nalukwago S; Chervenak K; Mayanja-Kizza H; Hawn TR; Boom WH
    Clin Infect Dis; 2019 May; 68(10):1705-1712. PubMed ID: 30165605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of latent tuberculosis infection in Sudan: a case-control study comparing interferon-γ release assay and tuberculin skin test.
    Shakak AO; Khalil EA; Musa AM; Salih KA; Bashir AE; Ahmed AH; Idris FE; Elhassan AM;
    BMC Public Health; 2013 Dec; 13():1128. PubMed ID: 24313987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Within-subject variability and boosting of T-cell interferon-gamma responses after tuberculin skin testing.
    van Zyl-Smit RN; Pai M; Peprah K; Meldau R; Kieck J; Juritz J; Badri M; Zumla A; Sechi LA; Bateman ED; Dheda K
    Am J Respir Crit Care Med; 2009 Jul; 180(1):49-58. PubMed ID: 19342414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon gamma response to combinations 38 kDa/CFP-10, 38 kDa/MPT-64, ESAT-6/MPT-64 and ESAT-6/CFP-10, each related to a single recombinant protein of Mycobacterium tuberculosis in individuals from tuberculosis endemic areas.
    Tavares RC; Salgado J; Moreira VB; Ferreira MA; Mello FC; Leung JW; Fonseca Lde S; Spallek R; Singh M; Saad MH
    Microbiol Immunol; 2007; 51(3):289-96. PubMed ID: 17380048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of isoniazid therapy for latent TB infection on QuantiFERON-TB gold in-tube responses in adults with positive tuberculin skin test results in a high TB incidence area: a controlled study.
    Johnson JL; Geldenhuys H; Thiel BA; Toefy A; Suliman S; Pienaar B; Chheng P; Scriba T; Boom WH; Hanekom W; Hatherill M
    Chest; 2014 Mar; 145(3):612-7. PubMed ID: 24135768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimal Detection of Latent Mycobacterium tuberculosis Infection by Combined Heparin-Binding Hemagglutinin (HBHA) and Early Secreted Antigenic Target 6 (ESAT-6) Whole-Blood Interferon Gamma Release Assays.
    Dirix V; Dauby N; Hites M; Watelet E; Van Praet A; Godefroid A; Petit E; Singh M; Locht C; Mascart F; Corbière V
    J Clin Microbiol; 2022 May; 60(5):e0244321. PubMed ID: 35430897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monokine induced by interferon gamma and IFN-gamma response to a fusion protein of Mycobacterium tuberculosis ESAT-6 and CFP-10 in Brazilian tuberculosis patients.
    Abramo C; Meijgaarden KE; Garcia D; Franken KL; Klein MR; Kolk AJ; Oliveira SC; Ottenhoff TH; Teixeira HC
    Microbes Infect; 2006 Jan; 8(1):45-51. PubMed ID: 16269263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T-cell and serological responses to Erp, an exported Mycobacterium tuberculosis protein, in tuberculosis patients and healthy individuals.
    Martinez V; Carcelain G; Badell E; Jouan M; Mauger I; Sellier P; Truffot C; Bricaire F; Arend SM; Ottenhoff T; Autran B; Gicquel B
    BMC Infect Dis; 2007 Jul; 7():83. PubMed ID: 17655752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-incubation-time gamma interferon release assays in response to purified protein derivative, ESAT-6, and/or CFP-10 for the diagnosis of Mycobacterium tuberculosis infection in children.
    Schepers K; Mouchet F; Dirix V; De Schutter I; Jotzo K; Verscheure V; Geurts P; Singh M; Van Vooren JP; Mascart F
    Clin Vaccine Immunol; 2014 Feb; 21(2):111-8. PubMed ID: 24152386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utility of interferon gamma/tumor necrosis factor alpha FluoroSpot assay in differentiation between active tuberculosis and latent tuberculosis infection: a pilot study.
    Zhang L; Wan S; Zhou Z; Zhang Y; Liu X
    BMC Infect Dis; 2021 Jul; 21(1):651. PubMed ID: 34225667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discrimination between active and latent tuberculosis based on ratio of antigen-specific to mitogen-induced IP-10 production.
    Jeong YH; Hur YG; Lee H; Kim S; Cho JE; Chang J; Shin SJ; Lee H; Kang YA; Cho SN; Ha SJ
    J Clin Microbiol; 2015 Feb; 53(2):504-10. PubMed ID: 25428147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.